Green light given to first Fosamax generics
First generic alendronate sodium tablets approved
The FDA has approved the first generic forms of alendronate sodium, formally only available as brand-name Fosamax (Teva Pharmaceuticals USA will commence manufacture of alendronate sodium tablets in 5-mg, 10-mg, and 40-mg dosages for once-daily administration, and 35-mg and 70-mg strengths for once-weekly use. In addition, Barr Laboratories was granted permission to market the 70-mg once-weekly alendronate tablet.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
